Abstract Studies of endothelial regulation of microvascular function have been hampered by the technical difficulty of removing the endothelium without damaging the vascular smooth muscle cells. This study presents a novel method of endothelial damage and lysis based on the facts that endothelial cells express specific antigens and that complement reacts with antibody/antigen complexes, causing cell lysis. We isolated and perfused rabbit glomerular afferent arterioles in vitro and examined vascular responses before and after treating them with an antibody against factor VIH-related antigen and complement. The treatment consisted of perfusing afferent arterioles with medium containing the antibody and complement for 10 minutes, followed by a 20-minute washout period. Before treatment, acetylcholine and the calcium ionophore A23187 (receptor-and nonreceptor-mediated endothelium-dependent vasodilators, respectively) dilated norepinephrine-preconstricted afferent arterioles, whereas neither dilated the arterioles after treatment, suggesting loss of endothelium-dependent vasodilation. In contrast, responses to nicardipine and norepinephrine (endothelium-independent vasodilator and constrictor, respectively) were not altered by the treatment, indicating intact vascular smooth muscle cell function. Transmission electron microscopy revealed that the antibody-and complement-treated arterioles had various degrees of endothelial damage, including areas of detachment from the basement membrane and marked loss of the number and structure of mitochondria, but no evidence of vascular smooth muscle cell damage. These results indicate that treatment with anti-factor VIH-related antigen antibody and complement is an effective method for eliminating endothelium-dependent vasodilation without altering endothelium-independent responses. Thus, this method may be useful for studying the functional role of the endothelium in microvessels. have been used to study its functional role in the regulation of vascular reactivity. Unfortunately, these methods are not readily applicable to microvessels, particularly to those with a diameter less than 20 nm. Because arterial microvessels of such sizes are considered true resistance vessels, the existence of a simple and reliable method of destroying the endothelium of these vessels would be of great value. Therefore, we wished to develop such a method taking advantage of the following facts: (1) endothelial cells express specific antigens, in this case factor VIII-related antigen (F8-RAg), and (2) complement reacts with antibody/antigen complexes, causing cell damage and lysis. We found that our method completely eliminates endothelium-dependent vasodilation from microperfused glomerular afferent arterioles (Af-Arts) without damaging vascular smooth muscle cells (VSMCs).
T he endothelium lining the vasculature has been recognized as an essential component for the regulation of regional vascular tone.
1 -* To date, several methods of destroying the endothelium, including chemical, enzymatic, and mechanical approaches, 37 have been used to study its functional role in the regulation of vascular reactivity. Unfortunately, these methods are not readily applicable to microvessels, particularly to those with a diameter less than 20 nm. Because arterial microvessels of such sizes are considered true resistance vessels, the existence of a simple and reliable method of destroying the endothelium of these vessels would be of great value. Therefore, we wished to develop such a method taking advantage of the following facts: (1) endothelial cells express specific antigens, in this case factor VIII-related antigen (F8-RAg), and (2) complement reacts with antibody/antigen complexes, causing cell damage and lysis. We found that our method completely eliminates endothelium-dependent vasodilation from microperfused glomerular afferent arterioles (Af-Arts) without damaging vascular smooth muscle cells (VSMCs). 
Methods
We obtained medium 199 from GIBCO, Grand Island, NY; bovine serum albumin (BSA), acetylcholine, norepinephrine, nicardipine, indomethacin, guinea pig complement, and A23187 from Sigma Chemical Co, St Louis, Mo; and goat anti-human F8-RAg antibody from Atlantic Antibodies (Incstar), Stillwater, Minn.
Isolation and Microperfusion of the Afferent Arteriole
Methods of microdissection and perfusion of Af-Arts have been described previously. 8 - 9 Briefly, a single superficial Af-Art with its glomerulus intact was microdissected from the kidney of each young male New Zealand White rabbit (1.4 to 2.2 kg) and transferred to a temperature-regulated chamber mounted on the stage of an inverted microscope. The Af-Art was then cannulated with an array of glass pipettes as described previously. 8 - 9 Intraluminal pressure was measured by the Landis technique, using a fine pipette introduced into the Af-Art through the perfusion pipette. The Af-Art was perfused with oxygenated medium 199 containing 5% BSA (M199-5%BSA), and intraluminal pressure was maintained at 60 mm Hg throughout the experiment.
The bath, which was identical to the arteriolar perfusate except that it contained 0.1% BSA, was exchanged continuously. Dissection and cannulation of the Af-Art were completed within 90 minutes at 8°C, after which the bath was warmed to 37°C for the remainder of the experiment. Once the temperature was stable, a 30-minute equilibration period was allowed before any measurements were taken. Images of the Af-Art were displayed at magnifications up to X1980 and recorded with a video system consisting of a camera (DXC-755, Sony), monitor (MA PVM-1942Q, Sony), and video recorder (EDV-9500, Sony). An image analysis system (Fryer Co, Carpentersville, 111) was used to measure luminal diameter.
Antibody/Complement Treatment of Afferent Arterioles
Antibody/complement treatment of Af-Arts consisted of perfusing the Af-Arts with M199-5%BSA containing goat anti-human F8-RAg antibody (14.29 mg/mL diluted 1:1000) plus 2% guinea pig complement for 10 minutes. The arterioles were then perfused (washed) with M199-5%BSA (containing neither the antibody nor complement) for 20 minutes.
Experimental Protocols

Effect of Acetylcholine on Luminal Diameter of Afferent Arterioles Before and After Antibody/Complement Treatment
After the equilibration period, the Af-Art was preconstricted to 50% of basal diameter by adding norepinephrine to the bath (the concentration necessary to achieve 50% constriction ranged from 2.5 to 7.5 xlO" 7 mol/L and was not different before or after antibody/complement treatment). Ten minutes later, acetylcholine, a receptor-mediated endothelium-dependent vasodilator, was added to the lumen at 10~6 and 10~! mol/L for 10 minutes at each dose. The bath exchange and arteriolar perfusate were then switched to control medium, and the Af-Art was allowed to recover for 20 minutes. The Af-Art was then treated with antibody/complement as described above, and the protocol was repeated.
Because we found that antibody/complement treatment abolished acetylcholine-induced vasodilation, we tested whether this was caused by increased production of cyclooxygenase-dependent vasoconstrictors (prostaglandin H 2 [PGH 2 ] and/or thromboxane) rather than diminished endotheliumdependent relaxing factor. For this, separate experiments were run in which Af-Arts were pretreated with 5xlO" 3 mol/L indomethacin and subjected to the antibody/complement treatment, after which the effect of acetylcholine was examined as before.
Effect of Calcium Ionophore A23187 on Afferent Arterioles Before and After Antibody/Complement Treatment
We next tested whether non-receptor-mediated endothelium-dependent vasodilation is altered by the antibody/complement treatment. Experimental protocols were the same as described in protocol 1 except that A23187 (10~7 and 10"' mol/L) was added to the lumen instead of acetylcholine.
Effect of Nicardipine on Afferent Arterioles Before and After Antibody/Complement
Treatment We examined whether arteriolar response to an endothelium-independent vasodilator was affected by the antibody/ complement treatment. Experimental protocols were the same as described in protocol 1, except that we added increasing doses of nicardipine (10"' to 10~7 mol/L) to both the bath and lumen instead of acetylcholine to the lumen.
Effect of Norepinephrine on Afferent Arterioles
Before and After Antibody/Complement Treatment We determined whether norepinephrine-induced vasoconstriction (endothelium-independent) was altered by the antibody/complement treatment. For this, dose-response curves for norepinephrine added to the bath (10~8 to 10" 6 mol/L) were obtained before and after antibody/complement treatment.
Electron Microscopy
After completion of the protocols, randomly selected Af-Arts were prepared for transmission electron microscopy. They were fixed in glutaraldehyde (3.0%) and sodium cacodylate (0.1 mol/ L), postfixed in 1.0% buffered OsO 4 , dehydrated in ascending grades of ethanol, and embedded in araldite resin. Thin sections were taken, stained with lead citrate and uranyl acetate, and viewed with a Philips 201 transmission electron microscope.
Data Analysis
Values are expressed as mean±SEM, and all statistical calculations were performed using absolute values. Differences between control and drug-related data (eg, norepinephrine, nicardipine, acetylcholine, and A23187) before and after antibody/complement treatment were detected with a twofactor ANOVA with repeated measures on both factors. Pairwise testing at the different concentration levels was performed using paired / tests, and a value of P<.017 was considered significant due to multiple testing (Bonferroni adjustment). shows the same Af-Art after the treatment; baseline diameter was essentially the same as before the treatment. Norepinephrine was again added to the bath to induce 50% constriction (panel F). In marked contrast to the vasodilator action of acetylcholine before the treatment, addition of acetylcholine did not dilate the Af-Art after the treatment (panels G and H). To demonstrate that the Af-Art was still capable of dilation, we added 10~7 mol/L nicardipine, an endothelium-independent vasodilator, which did indeed increase the diameter of the Af-Art (panel I). Fig 2A  depicts the mean data from five such experiments. Luminal diameter of Af-Arts before treatment was 17.7±0.9 /xm and decreased to 8.8±0.2 /xm when norepinephrine was added to the bath. Addition of 10~6 and 10~5 mol/L acetylcholine increased the diameter to 11.9±1.1 (/><.O15) and 16.2±0.9 ^m (/ ) <.001), respectively. After treatment, mean luminal diameter was 18.6±0.6 fim, and norepinephrine decreased it to 9.4±0.7 fim; neither value was significantly different from that obtained before the treatment. However, vasodilation in response to acetylcholine was abolished (ANOVA interaction, /><.001); in fact, acetylcholine now tended to decrease the diameter further to 6.9±2.1 and 5.7±1. demonstrated that there were no time-related alterations of acetylcholine action. The antibody/complement treatment also abolished acetyicholine-induced dilation in indomethacin-treated Af-Arts. In these experiments, luminal diameter was 17.5±0.7 fim (n=5) and decreased with norepinephrine to 8.6 ±1.0 fim. Neither 10" 6 nor 10" 3 mol/L acetylcholine altered the diameter significantly Huminal diameter was 7.8±0.7 and 7.4±0.8 /un at 10~* and 10" 5 mol/L acetylcholine, respectively). This suggests that loss of endothelium-dependent vasodilation after anti-F8-RAg/complement treatment is not due to increased release of cyclooxygenase-dependent constricting factors (PGH 2 and/or thromboxane). Fig 2B shows Af-Art responses to A23187 before and after antibody/complement treatment. Arteriolar diameter before treatment was 17.6±0.6 /im (n=5) and decreased to 8.6±0.8 ftm when norepinephrine was added to the bath. A23187 at 1(T 7 and 10" 6 mol/L increased the diameter to 12.6±1.1 (f<.015) and 15.8+1.3 fim (P<.001), respectively. After antibody/ complement treatment, mean luminal diameter was 18.0±0.9 ^.m, and norepinephrine decreased it to 9.7 ±0.7 ^m; neither value was significantly different 
Results
Effect of Acetylcholine on Luminal
Effect of the Calcium Ionophore A23187 on Afferent Arterioles Before and After Antibody/Complement Treatment
Effect of Nicardipine on Afferent Arterioles Before and After Antibody/Complement Treatment
Before treatment with anti-F8-RAg antibody/complement, the diameter of norepinephrine-constricted Af-Arts was 10.5 ±1.1 /itn (n=5). Nicardipine produced dose-dependent relaxation, with the diameter increasing to 12.9±1.0 (Z'=.O15) and 16.1 + 1.1 fim (P<.005) at 10" 8 and 10" 7 mol/L, respectively (Fig 3A) . After the treatment, the diameter of norepinephrineconstricted vessels was 11.3±1.1 ixm and increased to 14.9±1.1 (P<.01)>and 16.7±1.2 fim (P<M5) with 10" sponse to the endothelium-independent vasodilator is not altered, and consequently, the lack of a response to acetylcholine is not due to the inability of the VSMCs to relax.
Effect of Norepinephrine on Afferent Arterioles
Before and After Antibody/Complement Treatment Fig 3B shows the dose-response curve for norepinephrine before and after antibody/complement treatment. Basal diameter of the Af-Arts was 18.4±0.5 f±m (n=5) before treatment and 18.5±0.6 fim afterward. As the figure clearly demonstrates, norepinephrine caused almost identical dose-dependent decreases in diameter before and after treatment. Norepinephrine at 10" 7 , 5xlO" 7 , and 10" 6 mol/L decreased the diameter to 17.1±0.6, 11.5±2.0, and 4.9±1.9 fim, respectively, before treatment and to 17.2±0.7, 10.0±2.4, and 4.8±3.0 /an afterward. These data show that the Af-Art response to norepinephrine was normal after antibody/ complement treatment.
Electron Microscopy
Ultrastructural examination of control (Fig 4, top) and antibody/complement-treated Af-Arts (bottom) revealed that the treatment produced variable degrees of damage to the endothelium, including increased vacuolation, marked loss in the number and structure of mitochondria, and nuclear membrane damage, as well as areas of endothelial detachment from the basement membrane. Intracellular structures of the VSMCs were well preserved, and there was no evidence of cellular damage.
Discussion
The present report describes a novel protocol for removal of endothelium-dependent vasodilation from isolated microvessels by perfusing them with an anti-F8-RAg antibody and complement. With this method, the endothelium appeared to be selectively damaged without detectable changes in VSMCs.
The contention that the antibody/complement treatment causes loss of functional endothelium without damaging VSMCs is supported by several findings of the present study. First, the treatment abolished the action of endothelium-dependent vasodilators. Second, acetylcholine-induced vasodilation was not restored by indomethacin treatment, indicating that the loss of endothelium-dependent vasodilation was due to diminished endothelium-derived relaxing factor rather than increased PGH 2 and/or thromboxane (as occurs in some forms of hypertension and atherosclerosis). Third, the treatment did not alter vascular responses to endothelium-independent vasoactive agents (nicardipine and norepinephrine). It is important to point out that we used norepinephrine because, unlike angiotensin II 8 or endothelin, 9 its vasoconstrictor action on Af-Arts is not augmented by blockade of nitric oxide synthesis; therefore, one would not expect destruction of the endothelium to affect norepinephrine-induced constriction of Af-Arts. Finally, ultrastructural analysis demonstrated that treatment clearly damaged the endothelial cells along the Af-Art, but there were no signs of damage to the VSMCs. We have previously found that 7V°-nitro-L-argininemethyl ester (L-NAME), an inhibitor of endotheliumderived relaxing factor/nitric oxide (EDRF/NO), causes a 20% decrease in the diameter of Af-Arts. 89 In contrast, the present study shows that endothelium disruption with antibody/complement treatment does not cause constriction, a finding that has also been observed in pig coronary arterioles. 5 -10 This apparent discrepancy could be due to several reasons. First, endothelial disruption would be expected to eliminate all endothelial factors (dilating and constricting factors), whereas L-NAME only eliminates EDRF/NO; thus, the continued presence of endothelium-derived constricting factors might account for the constriction seen with L-NAME. It is also possible that L-NAME-induced vasoconstriction is independent of EDRF/NO (as suggested previously"" 13 ). These possibilities require further investigation.
A growing number of studies describe the complex interactions between the VSMCs and endothelium. Studies have suggested that the endothelium modulates and/or mediates vascular responses to several vasoactive stimuli, including flow-induced vasodilation, stretch/pressure-induced vasoconstriction, and responses to vasoactive agents. 17 Although these contradictory findings may be due to differences in the species and vascular beds studied, an important additional factor may be the method used to eliminate the endothelium. Previous methods of endothelial damage and destruction were not specific for endothelial cells, and thus one cannot unequivocally eliminate the possibility of nonspecific damage to VSMCs. Because a certain degree of damage to the VSMCs in isolated arterioles compromises certain vascular properties (eg, basal tone) more than others (eg, responses to KC1), 4 -6 - 18 it is possible that the divergent findings in previous studies may be due to different degrees of VSMC damage that may occur with different methods of endothelial denudation. This may be especially important in resistance vessels, as small vessels may be more susceptible to damage than large ones. 5 The antibody/complement method described in this study should have a clear advantage over previous methods of endothelial damage and destruction. First, it specifically attacks cells that are positive for F8-RAg (eg, endothelial cells) without damaging VSMCs, which do not contain FS-RAg. 19 - 20 Second, for chemical and enzymatic methods to consistently and reliably remove the endothelium without damaging the VSMCs, it is essential to have strict control of the conditions (eg, time of exposure to the chemical or enzyme). In contrast, with our anti-F8-RAg antibody/complement method, such precise control is not necessary because of its specificity; this is especially important in systems like ours in which the time for a complete exchange of solutions cannot be controlled precisely. Third, this method is easy to learn and use, whereas mechanical methods are extremely tedious to use in microvessels (and in fact cannot be used in preparations such as ours). Thus, the ability of this technique to damage and destroy endothelial cells specifically, combined with the fact that it is easy to learn, should make it a very useful tool for studying the role of the endothelium in vascular function.
